February 25, 2022
The Tokyo District Court on February 24 dismissed Chugai Pharmaceutical’s claim in a patent infringement suit it has filed against three companies, including two of Big 3 generic makers, over its osteoporosis treatment Edirol (eldecalcitol). The lawsuit, which focuses on...read more